Pemetrexed plus rituximab as second-line treatment for primary central nervous system lymphoma
Crossref DOI link: https://doi.org/10.1007/s12032-014-0351-7
Published Online: 2014-11-27
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhao, Hai-Tao
Chen, Jing
Shi, Sheng-bin
Tian, Jing
Tao, Rong-Jie
Text and Data Mining valid from 2014-11-27